Real-world faricimab data shows improvements in VA in patients with wet AMD

In patients with neovascular age-related macular degeneration (nAMD) treated with faricimab in a real-world setting, improvements in visual acuity and anatomic parameters were demonstrated at an early time point, according to data presented at ASRS 2022. In this retrospective study, treatment-naïve patients and patients who switched to faricimab from other...